This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Share
Stay up to date

Home
Topics
Webinars/Videos
Infographics
Articles
Case Studies
Forum
Faculty
Unblocked
Stay up to date

Articles

Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia

Zoulek S, Shriver J, Kaur N, et al.

Journal:

J Clin Lipidol

First published: November 16, 2023 DOI: 10.1016/j.jacl.2023.11.005

Abstract

You might also like...

Running time: 12 minutes
Webinars/Videos
ESC Congress 2022 Highlights – Peer-to-Peer Discussion – Part Two
Watch part two of the ESC Highlights Video wherein Prof. Christopher Cannon and Prof. Lale Tokgözoğlu discuss results of some exciting trials highlighting the significance of Lp(a), PCSK9 inhibitors, patient adherence and compliance.
Zoulek S, Shriver J, Kaur N, et al.
Journal:
J Clin Lipidol

First published: November 16, 2023 DOI: 10.1016/j.jacl.2023.11.005
View
- Share
Infographics
Proprotein Convertase Subtilisin/Kexin Type 9 in Cholesterol Homeostasis, Inflammation, and Thrombosis Associated with Cardiovascular Diseases
An overview of molecular functions and therapeutic strategies
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in cholesterol homeostasis and inflammation, platelet activation, and atherosclerosis disease progression.
This infographic presents the physiological functions and molecular features that make PCSK9 an attractive therapeutic target for cardiovascular diseases.
Various strategies for targeting PCSK9 and clinical trials involving PCSK9-inhibitors are also delineated.
Zoulek S, Shriver J, Kaur N, et al.
Journal:
J Clin Lipidol

First published: November 16, 2023 DOI: 10.1016/j.jacl.2023.11.005
View
- Share
Case Studies
Quiz of the month – March 2023
As an HCP would you use a plain language infographic as a tool to explain atherosclerosis and lipid lowering to your patients?
Zoulek S, Shriver J, Kaur N, et al.
Journal:
J Clin Lipidol

First published: November 16, 2023 DOI: 10.1016/j.jacl.2023.11.005
Take
- Share

How would you rate this content?

© John Wiley & Sons, Ltd. All rights reserved.
Privacy Policy
Terms of use
Stay up to date
Cookie Preferences
This Knowledge Hub is supported by Novartis.